News Conference News ESC 2022 Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE Michael O'Riordan August 31, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ESC 2022 Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration Michael O'Riordan August 29, 2022
News Daily News After COVID-19, Unvaccinated at Risk for Long-term CVD Complications Michael O'Riordan August 16, 2022
News Daily News Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis Yael L. Maxwell August 16, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Daily News Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed Todd Neale August 12, 2022
News Daily News Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution Michael O'Riordan August 11, 2022
News Daily News Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression Michael O'Riordan August 08, 2022
News Daily News Women With Early Menopause See Higher Heart Failure, AF Risks Yael L. Maxwell August 04, 2022
News Daily News Meat Consumption and Gut Microbiome Linked to ASCVD Risk Yael L. Maxwell August 03, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2022 Todd Neale August 01, 2022
News Daily News Smoking Linked With Worse Outcomes in Hospitalized COVID-19 Patients Michael O'Riordan July 29, 2022
News Daily News USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits Michael O'Riordan July 27, 2022
News Daily News AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death Caitlin E. Cox July 22, 2022
News Daily News CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans Yael L. Maxwell July 22, 2022
News Daily News Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19 Michael O'Riordan July 20, 2022
News Daily News Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy Todd Neale July 20, 2022